ICON provides a full range of laboratory services that are dedicated exclusively to clinical development.
For over 25 years, the bioanalytical services group at ICON has provided analytical testing services to meet the research and development challenges of the pharmaceutical and biotechnology industry.
ICON Central Laboratories is dedicated exclusively to central laboratory testing and the associated services for clinical trials.
Our laboratories are located in key global regions, including the US, Singapore, India, China and Ireland. All ICON laboratories use state of the art instrumentation and equipment and are either GCP or GLP as well as CAP accredited.
The move to Beijing represents the successful conclusion of a complex relocation project, which included operation from a temporary facility in Shanghai while the former lab location in Tianjin was decommissioned. During all this time, service to clients was maintained without interruption. While ICON Labs has had a presence in China since 2007, this is the first time that the lab will be co-located with other ICON services in Beijing.
The new 950 sqm facility will support global drug development and will also house ICON clinical research and other staff. Current testing services include hematology, chemistry, urinalysis, coagulation, immunology, HbA1c and DNA extraction. A range of specialty lab testing capabilities such as histopathology, PCR, slide imaging and ELISA will be installed by the end of 2020. BioA lab capacity is also planned for the future.